US EditionPublished • loading... • Updated
Microbix Schedules Release of Results for Q4 Fiscal 2025
- Microbix Biosystems Inc. plans to file its Q4 2025 financial statements on December 18, 2025, before trading starts.
- At 10:00 AM ET on December 18, Microbix will hold a webinar with its CEO, CFO, and COO to discuss Q4 2025 results.
- Investors can register for the webinar hosted by Adelaide Capital through a provided link.
- Microbix is headquartered in Mississauga, Ontario, Canada, and is traded on the TSX and OTCQX.
Insights by Ground AI
10 Articles
10 Articles
NiagaraFallsReview.ca+9 Reposted by 9 other sources
Microbix Schedules Release of Results for Q4 Fiscal 2025
MISSISSAUGA, Ontario, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release…
·Niagara Falls, Canada
Read Full ArticleCoverage Details
Total News Sources10
Leaning Left7Leaning Right2Center1Last UpdatedBias Distribution70% Left
Bias Distribution
- 70% of the sources lean Left
70% Left
L 70%
R 20%
Factuality
To view factuality data please Upgrade to Premium
